Vaccines for pneumonia and new antiviral therapies

Medical Clinics of North America

Volumn 85, Issue 6, 2001, Pages 1531-1544

  Gross, Peter A ^a,b  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; BACTERIAL VACCINE; INFLUENZA VACCINE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; RICKETTSIA VACCINE; RIMANTADINE; VIRUS VACCINE; ZANAMIVIR;

ALLERGIC REACTION; ANTIVIRAL ACTIVITY; CHEMOPROPHYLAXIS; DRUG EFFICACY; ERYTHEMA; FEVER; HUMAN; INFECTION RATE; MALAISE; MYALGIA; PNEUMONIA; PRIORITY JOURNAL; RASH; REVIEW; VACCINATION; VIRUS INACTIVATION;

EID: 0034774440     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70394-1     Document Type: Article

References (49)

1. Policy Statement and Technical Report: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevenar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis
2. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children
3. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth-Lederle) in 37,000 infants and children: Impact on pneumonia, otitis media, and an update on invasive disease results of the Northern California Permanente Efficacy Trial
4. A target-based model for increasing influenza immunizations in private practice
5. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States 1978-1994: Implications for development of a conjugate vaccine
6. The Hawaii pneumococcal disease initiative
7. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial
8. Assessing adult vaccination status at age 50 years
9. Immunization of adolescents: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
10. Neuraminidase inhibitors for treatment of influenza A and B infections
11. Pneumococcal immunization program - California, 1986-1988
12. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
13. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
14. Effect of medical records' checklists on implementation of periodic health measures
15. A strategy to improve the utilization of pneumococcal vaccine
16. Improving physician compliance with preventive medicine guidelines
17. Hospital-based strategies for improving influenza vaccination rates
18. Efficacy of a heptavalent pneumococcal conjugate vaccine (PncCRM) against serotype-specific, culture-confirmed pneumococcal acute otitis media (AOM) in infants and children
19. Pneumococcal conjugate vaccines
20. Discontinuing penicillin prophylaxis in children with sickle cell anemia
21. Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: A review of its rationale and implications
22. Hospital-based pneumococcal immunization: Epidemiologic rationale from the Shenandoah Study
23. Clinical effectiveness of influenza vaccination in Manitoba
24. Immunization of adults
25. Prophylaxis with oral penicillin in children with sickle cell anemia
26. Emerging infections: Pandemic influenza
27. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
28. Evaluation of the effectiveness of immunization delivery methods
29. Clinical and epidemiological importance of influenza A viruses resistant to amantadine and rimantadine
30. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections
31. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza
32. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-81: Lack of an association with influenza vaccination
33. An effective hospital-based pneumococcal immunization program
34. Frequency of adverse reactions to influenza vaccine in the elderly: A randomized, placebo-controlled trial
35. Randomized trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
36. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
37. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children
38. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
39. Effectiveness of live, attenuated intranasal influenzavirus vaccine in healthy, working adults
40. Severe pneumococcal pneumonia in previously health children: The role of preceding influenza infection
41. The burden of pneumococcal disease: The role of conjugate vaccines
42. 197 in United States infants
43. Pneumococcal immunization: From policy to practice
44. 197 conjugate vaccine in infants and toddlers
45. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people
46. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial